Singapore markets closed

LLY Apr 2024 630.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
2.0100-0.2400 (-10.67%)
At close: 03:24PM EST
Full screen
Previous close2.2500
Open1.9100
Bid0.9900
Ask2.3000
Strike630.00
Expiry date2024-04-19
Day's range1.9100 - 2.1500
Contract rangeN/A
Volume6
Open interest249
  • Insider Monkey

    20 Fastest Growing Biotech Companies in the US

    In this article, we will be taking a look at the 20 fastest growing biotech companies in the US. If you are not interested in learning about the landscape of biotech companies, head straight to the 5 Fastest Growing Biotech Companies In The US. The biotechnology sector in the United States is witnessing a surge […]

  • Zacks

    Zacks Market Edge Highlights: AAPL, COST, WSM, LLY and HLT

    AAPL, COST, WSM, LLY and HLT have been highlighted in this Market Edge article.

  • Reuters

    Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says

    The widespread use of powerful new weight-loss drugs in the United States could boost gross domestic product by 1% in the coming years as lower obesity-related complications are likely to boost workplace efficiency, according to Goldman Sachs. Some analysts have predicted the market for weight-loss drugs could reach $100 billion a year by the end of the decade, with Ozempic maker Novo Nordisk and Mounjaro producer Eli Lilly leading the race. The use of GLP-1s could increase by anywhere between 10 to 70 million consumers by 2028, Goldman Sachs said on Thursday.